Concord Medical Services Holdings Ltd
About Concord Medical Services Holdings Ltd
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Geographically, the company derives revenue from PRC.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $65.0M
- Net income
- -$13.3M
- Total assets
- $936.3M
- Market cap
- $20.8M
Source: SEC EDGAR · updated Jun 7, 2026
- Market cap
- $20.8M
- Shares outstanding
- 4.3M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Dec 11, 2009
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $13.3M in FY2025.
- Trading 45% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Concord Medical Services Holdings Ltd.
Write a review
News about Concord Medical Services Holdings Ltd
News & sentiment via Polygon.io
